Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Retraction notice to "High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease" Bone Volume 23, Issue 6, December 1998, Pages 555-557.

Sato Y, Asoh T, Oizumi K.

Bone. 2019 Aug;125:210. doi: 10.1016/j.bone.2019.05.019. Epub 2019 May 16. No abstract available.

PMID:
31103716
2.

Expression of concern: Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients.

Sato Y, Kuno H, Asoh T, Honda Y, Oizumi K.

Age Ageing. 2019 Feb 5:312. doi: 10.1093/ageing/afy221. [Epub ahead of print] No abstract available.

PMID:
30721916
3.

Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes.

Oizumi K, Sekine S, Fukagai M, Susukida T, Ito K.

J Pharm Sci. 2017 Sep;106(9):2412-2419. doi: 10.1016/j.xphs.2017.05.017. Epub 2017 May 26.

PMID:
28552691
4.

Corrigendum: Suppression of B function strongly supports the modified ABCE model in Tricyrtis sp. (Liliaceae).

Otani M, Sharifi A, Kubota S, Oizumi K, Uetake F, Hirai M, Hoshino Y, Kanno A, Nakano M.

Sci Rep. 2017 Feb 9;7:42322. doi: 10.1038/srep42322. No abstract available.

5.

The (oxalato)aluminate complex as an antimicrobial substance protecting the "shiro" of Tricholoma matsutake from soil micro-organisms.

Nishino K, Shiro M, Okura R, Oizumi K, Fujita T, Sasamori T, Tokitoh N, Yamada A, Tanaka C, Yamaguchi M, Hiradate S, Hirai N.

Biosci Biotechnol Biochem. 2017 Jan;81(1):102-111. Epub 2016 Oct 3.

PMID:
27691719
6.

Suppression of B function strongly supports the modified ABCE model in Tricyrtis sp. (Liliaceae).

Otani M, Sharifi A, Kubota S, Oizumi K, Uetake F, Hirai M, Hoshino Y, Kanno A, Nakano M.

Sci Rep. 2016 Apr 15;6:24549. doi: 10.1038/srep24549. Erratum in: Sci Rep. 2017 Feb 09;7:42322.

7.

Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.

Susukida T, Sekine S, Nozaki M, Tokizono M, Oizumi K, Horie T, Ito K.

J Pharm Sci. 2016 Apr;105(4):1550-60. doi: 10.1016/j.xphs.2016.01.013. Epub 2016 Mar 4.

PMID:
26952880
8.

Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.

Susukida T, Sekine S, Ogimura E, Aoki S, Oizumi K, Horie T, Ito K.

Toxicol In Vitro. 2015 Oct;29(7):1454-63. doi: 10.1016/j.tiv.2015.06.004. Epub 2015 Jun 6.

PMID:
26055650
9.

Discovery and structure-activity relationship of thienopyridine derivatives as bone anabolic agents.

Saito K, Nakao A, Shinozuka T, Shimada K, Matsui S, Oizumi K, Yano K, Ohata K, Nakai D, Nagai Y, Naito S.

Bioorg Med Chem. 2013 Apr 1;21(7):1628-42. doi: 10.1016/j.bmc.2013.01.071. Epub 2013 Feb 11.

PMID:
23453217
10.

A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model.

Yoshiko Y, Oizumi K, Hasegawa T, Minamizaki T, Tanne K, Maeda N, Aubin JE.

PLoS One. 2010 Jul 26;5(7):e11782. doi: 10.1371/journal.pone.0011782.

11.

The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.

Hasegawa T, Oizumi K, Yoshiko Y, Tanne K, Maeda N, Aubin JE.

BMC Dev Biol. 2008 Jul 14;8:71. doi: 10.1186/1471-213X-8-71.

12.

Accelerated bone remodeling in patients with poststroke hemiplegia.

Sato Y, Fujimatsu Y, Honda Y, Kunoh H, Kikuyama M, Oizumi K.

J Stroke Cerebrovasc Dis. 1998 Jan-Feb;7(1):58-62.

PMID:
17895057
13.

Leukemia inhibitory factor influences the fate choice of mesenchymal progenitor cells.

Falconi D, Oizumi K, Aubin JE.

Stem Cells. 2007 Feb;25(2):305-12.

14.

Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan.

Saito A, Kohno S, Matsushima T, Watanabe A, Oizumi K, Yamaguchi K, Oda H; Study Group.

J Infect Chemother. 2006 Apr;12(2):63-9.

PMID:
16648944
15.

Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method.

Saito A, Hiraga Y, Watanabe A, Saito A, Shimada K, Kobayashi H, Odagiri S, Miki F, Soejima R, Oizumi K, Hara K, Nakashima M; Japanese Cefcapene Study Group.

J Int Med Res. 2004 Nov-Dec;32(6):590-607.

PMID:
15587753
16.

Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury.

Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H, Yodoi J.

Am J Respir Crit Care Med. 2003 Nov 1;168(9):1075-83. Epub 2003 Jun 19.

PMID:
12816738
17.

Antiphospholipid syndrome and multiple ischemic strokes in a patient with myasthenia gravis.

Kaji M, Sato Y, Kunoh H, Watanabe A, Aizawa H, Oizumi K, Abe T.

Kurume Med J. 2002;49(4):211-6.

18.

[Clinical evaluation of azithromycin for respiratory infectious diseases].

Oizumi K.

Jpn J Antibiot. 2000 Jun;53 Suppl B:72-81. Review. Japanese.

PMID:
12572090
19.

Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study.

Miyashita N, Saito A, Kohno S, Oizumi K, Yamaguchi K, Watanabe A, Oda H, Fukano H, Yoshida K, Niki Y, Matsushima T.

Intern Med. 2002 Nov;41(11):943-9.

20.

Bacteremic and leukopenic pneumococcal pneumonia: successful treatment with antibiotics, pulse steroid, and continuous hemodiafiltration.

Yokoyama T, Sakamoto T, Shida N, Shimada T, Kaku N, Aizawa H, Oizumi K.

J Infect Chemother. 2002 Sep;8(3):247-51.

PMID:
12373489
21.

Efficacy of common antiseptics against multidrug-resistant Mycobacterium tuberculosis.

Rikimaru T, Kondo M, Kajimura K, Hashimoto K, Oyamada K, Miyazaki S, Sagawa K, Aizawa H, Oizumi K.

Int J Tuberc Lung Dis. 2002 Sep;6(9):763-70.

PMID:
12234131
22.

Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer.

Gohara R, Imai N, Rikimaru T, Yamada A, Hida N, Ichiki M, Kawamoto M, Matsunaga K, Ashihara J, Yano S, Tamura M, Ohkouchi S, Yamana H, Oizumi K, Itoh K.

J Immunother. 2002 Sep-Oct;25(5):439-44.

PMID:
12218782
23.

Effects of human recombinant calcitonin on a rat osteopenia model induced by TPTX and arotinoid.

Fukuda C, Oizumi K, Ohhata K, Kiyokawa A, Katsumata M, Ishikawa H, Miyamoto M.

Calcif Tissue Int. 2002 Jul;71(1):80-7. Epub 2002 Jun 5.

PMID:
12200658
24.

Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia.

Tanaka M, Tanaka K, Fukahori S, Fujimatsu Y, Jojima H, Shiraishi K, Honda J, Oizumi K.

Hematology. 2002 Apr;7(2):105-8.

PMID:
12186700
25.

Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples.

Kafwabulula M, Ahmed K, Nagatake T, Gotoh J, Mitarai S, Oizumi K, Zumla A.

Int J Tuberc Lung Dis. 2002 Aug;6(8):732-7.

PMID:
12150487
26.

Bactericidal activities of commonly used antiseptics against multidrug-resistant mycobacterium tuberculosis.

Rikimaru T, Kondo M, Kajimura K, Hashimoto K, Oyamada K, Sagawa K, Tanoue S, Oizumi K.

Dermatology. 2002;204 Suppl 1:15-20.

PMID:
12011515
27.

[A three-year review of acute respiratory tract infections caused by Streptococcus milleri group].

Fujiki R, Kawayama T, Rikimaru T, Oizumi K.

Kansenshogaku Zasshi. 2002 Mar;76(3):174-9. Japanese.

PMID:
11974885
28.

Clinical study of severe influenza virus pneumonia that caused acute respiratory failure.

Kawayama T, Fujiki R, Rikimaru T, Oizumi K.

Kurume Med J. 2001;48(4):273-9.

29.

Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia.

Okamoto M, Kato S, Oizumi K, Kinoshita M, Inoue Y, Hoshino K, Akira S, McKenzie AN, Young HA, Hoshino T.

Blood. 2002 Feb 15;99(4):1289-98.

PMID:
11830478
30.

Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the Committee for the Respiratory System, Japan Society of Chemotherapy.

Saito A, Miki F, Oizumi K, Rikitomi N, Watanabe A, Koga H, Niki Y, Kusano N.

J Infect Chemother. 1999 Jun;5(2):110-123.

31.

Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.

Masuoka M, Yoshimuta T, Hamada M, Okamoto M, Fumimori T, Honda J, Oizumi K, Itoh K.

Viral Immunol. 2001;14(4):369-77.

PMID:
11792066
32.

Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.

Honda S, Migita K, Hirai Y, Origuchi T, Yamasaki S, Kamachi M, Shibatomi K, Fukuda T, Kita M, Hida A, Ida H, Aoyagi T, Kawakami A, Kawabe Y, Oizumi K, Eguchi K.

Clin Exp Immunol. 2001 Oct;126(1):131-6.

33.

Clinical utility of capillary polymerase chain reaction for diagnosis of Cytomegalovirus pneumonia.

Honda J, Yonemitsu J, Kitajima H, Yosida N, Fumirori T, Oizumi K.

Scand J Infect Dis. 2001;33(9):702-5.

PMID:
11669230
34.

Interleukin-4 is needed for the infection of monocytes by human cytomegalovirus.

Kitajima H, Okubo Y, Honda J, Yonemitsu J, Yoshida N, Fumimori T, Oizumi K.

Intervirology. 2001;44(4):264-70.

PMID:
11509890
35.

Elevated serum myosin light chain I in influenza patients.

Kaji M, Kuno H, Turu T, Sato Y, Oizumi K.

Intern Med. 2001 Jul;40(7):594-7.

36.

Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids.

Rikimaru T, Koga T, Sueyasu Y, Ide S, Kinosita M, Sugihara E, Oizumi K.

Int J Tuberc Lung Dis. 2001 Aug;5(8):769-74.

PMID:
11495269
37.

[Costs of influenza therapy].

Kaji M, Kuno H, Oizumi K.

Kansenshogaku Zasshi. 2001 Jun;75(6):460-3. Japanese.

PMID:
11494561
38.

Changes in bone and calcium metabolism following hip fracture in elderly patients.

Sato Y, Kaji M, Higuchi F, Yanagida I, Oishi K, Oizumi K.

Osteoporos Int. 2001;12(6):445-9.

PMID:
11446559
39.

[Efficacy and safety of influenza vaccination to elderly patients with neurological diseases].

Kaji M, Tsuru T, Oizumi K.

Kansenshogaku Zasshi. 2001 May;75(5):411-5. Japanese.

PMID:
11424491
40.

In vitro transmission of HCMV between fibroblasts and peripheral blood leukocytes in the presence of IL-4.

Kitajima H, Okubo Y, Honda J, Yonemitsu J, Yoshida N, Fumimori T, Yoshimuta T, Hamada M, Oizumi K.

Kurume Med J. 2001;48(1):37-42.

41.

Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function.

Hoshino T, Kawase Y, Okamoto M, Yokota K, Yoshino K, Yamamura K, Miyazaki J, Young HA, Oizumi K.

J Immunol. 2001 Jun 15;166(12):7014-8.

42.

Different neural systems for recognizing plants, animals, and artifacts.

Kawashima R, Hatano G, Oizumi K, Sugiura M, Fukuda H, Itoh K, Kato T, Nakamura A, Hatano K, Kojima S.

Brain Res Bull. 2001 Feb;54(3):313-7.

PMID:
11287136
43.

[Clinical significance of eosinophilic cationic protein in serum and bronchoalveolar lavage fluid of adult patients with mycoplasmal pneumonia].

Yano T, Saito S, Arikawa K, Kitazato Y, Koga H, Kumazawa J, Honda J, Oizumi K.

Kansenshogaku Zasshi. 2001 Jan;75(1):36-41. Japanese.

PMID:
11218384
44.

[Drug induced immunodeficiency].

Hotta M, Rikimaru T, Oizumi K.

Ryoikibetsu Shokogun Shirizu. 2000;(32):436-9. Review. Japanese. No abstract available.

PMID:
11212768
45.

[Immunodeficiency induced by antineoplastic agents].

Ichiki M, Rikimaru T, Oizumi K.

Ryoikibetsu Shokogun Shirizu. 2000;(32):433-5. Review. Japanese. No abstract available.

PMID:
11212767
46.

Good's syndrome presenting with cytomegalovirus pneumonia.

Ide S, Koga T, Rikimaru T, Katsuki Y, Oizumi K.

Intern Med. 2000 Dec;39(12):1094-6.

47.

Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging.

Tanaka M, Honda J, Imamura Y, Shiraishi K, Tanaka K, Oizumi K.

Pathobiology. 2000 May-Jun;68(3):124-8.

PMID:
11174069
48.

Serum beta2-microglobulin reflects increased bone resorption in immobilized stroke patients.

Sato Y, Kuno H, Kaji M, Tsuru T, Saruwatari N, Oizumi K.

Am J Phys Med Rehabil. 2001 Jan;80(1):19-24.

PMID:
11138950
49.

Risk factors for hip fracture among elderly patients with Parkinson's disease.

Sato Y, Kaji M, Tsuru T, Oizumi K.

J Neurol Sci. 2001 Jan 1;182(2):89-93.

PMID:
11137512
50.

Supplemental Content

Loading ...
Support Center